[Insulin resistance in patients with metabolic syndrome and cholelithiasis].
The aim of the study was to determine serum insulin level in patients with metabolic syndrome (MS), pronounced manifestation of cholelithiasis (CL), and abdominal obesity. The measurements were compared with hyperlipidemia and glycemia levels in these patients. The subjects were 55 women with MS, divided into two groups according to 1991 Kh. Kh. Mansurov's classification of CL stages. Insulin level was measured by immune-enzyme assay; carbohydrate and lipid metabolism (lipid levels, lipoprotein and fatty acid spectrums, malonic dialdehyde and catalase levels)--by conventional methods. The study revealed a correlation between high insulin level in patients with hyperglycemia, disorder of tolerance to glucose, and type II diabetes, on the one hand, and lipid peroxidation level and dislipidemia, on the other. The study also found high insulin level at various stages of CL, especially during the period of concrement formation. Insulin is a CL risk factor, i.e. it elevates the risk of nucleation.
Mansurov
Kh Kh
KhKh
Mirodzhov
G K
GK
Mansurova
F Kh
FKh
Dustov
A D
AD
Mirzoeva
P F
PF
Mutikhova
Kh Sh
KhSh
D000328:Adult; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D002374:Catalase / Q000097:blood; D002769:Cholelithiasis / Q000097:blood* / Q000150:complications; D005227:Fatty Acids / Q000097:blood; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007328:Insulin / Q000097:blood*; D007333:Insulin Resistance / Q000502:physiology; D015227:Lipid Peroxidation; D008074:Lipoproteins / Q000097:blood; D008315:Malondialdehyde / Q000097:blood; D024821:Metabolic Syndrome / Q000097:blood* / Q000150:complications; D008875:Middle Aged
D015415:Biomarkers; D001786:Blood Glucose; D005227:Fatty Acids; D007328:Insulin; D008074:Lipoproteins; D008315:Malondialdehyde; D002374:Catalase